• Microfluidics News Admin

[Conference]Stem Cells for Drug Discovery & Toxicity Screening 2017 - July 10 - 11, 2017

Date: Monday, 10 July 2017 - Tuesday, 11 July 2017


Wyndham Boston Beacon Hill5 Blossom Street,Boston, Massachusetts, 02114, USATelephone: +1-617-742-7630


Link: http://selectbiosciences.com/conferences/index.aspx?conf=SCDDUS2017

Overview (from link above):

Select Biosciences, Inc. Stem Cells in Drug Discovery & Toxicity Screening 2017 is held concurrently with the Select Biosciences, Inc. Third Annual Organ-on-a-Chip World Congress 2017 focuses on an important and expanding field wherein cells are being assembled using Microfluidics and Lab-on-a-Chip technologies in a functionally-relevant manner. These clusters of "assembled cells" have functional significance and can mimic in vivo organ structure. Liver cells assembled on-board chips in a physiologically-relevant architecture using microfluidics can, for instance, be utilized for toxicity screening and the ability to assemble organ fragments ex vivo can provide an exquisite means to reconstruct biological processes (both physiological and pathological) "in a dish" or "on a chip." A number of chips such Lung-on-a-Chip, Brain-on-a-Chip, Gut-on-a-Chip, Marrow-on-a-Chip, Bone-on-a-Chip, Nerve-on-a-Chip amongst others have been built and will be presented and explored at this conference. We will also focus on "disease-on-a-chip", cancer-on-a-chip, immune system-on-a-chip and toxicity screening-on-a-chip. The Three Conference Tracks are Co-Located and Concurrent and Delegates can Participate, Mix-and-Match Presentations and Network Extensively with their Colleagues from all 3 Conference Tracks. Co-Located, Concurrent Conference Tracks:

  • Organ-on-a-Chip World Congress 2017

  • 3D-Culture 2017

  • Stem Cells in Drug Discovery & Toxicity Screening 2017

All the Key Opinion Leaders from around the World are Participating at this Conference allowing Maximal Information Exchange and Unparalleled Networking Opportunities.

Keynote Speakers:

Roger Kamm Cecil and Ida Green Distinguished Professor of Biological and Mechanical Engineering, Massachusetts Institute of Technology (MIT)

Devyn Smith Head of Strategy, R&D Division, Pfizer

Ksenia Blinova Senior Technical Manager, Induced Pluripotent Stem Cell and Electrophysiology Core Facility, Center for Devices and Radiological Health (CDRH), US Food and Drug Administration (FDA)

Geraldine A Hamilton President/Chief Scientific Officer, Emulate Inc

Michael Shuler Samuel B. Eckert Professor of Engineering, Cornell University; President & CEO, Hesperos, Inc.

Tommy Andersson Cardiovascular and Metabolic Diseases, Innovative Medicines and Early Development Biotech Unit, AstraZeneca R&D Mölndal

Linda Griffith Professor, Massachusetts Institute of Technology (MIT)

John Wikswo A.B. Learned Professor of Living State Physics; Founding Director, Vanderbilt Institute for Integrative Biosystems, Vanderbilt University

Norio Nakatsuji Chief Advisor, Stem Cell & Device Laboratory, Inc. (SCAD); Professor Emeritus, Kyoto University

Gary Gintant Research Fellow, Abbvie


Recent Posts

See All

© 2017 by "Microfluidics News".